OPIOID ADDICTION PREVENTION TRAINING FOR NEW JERSEY MENTAL HEALTH PROFESSIONALS
ENDURING RECORDED COURSE: Registration now open
Time of Enduring Recorded Course: One hour
This is the third of six modules of a live webinar and enduring recorded course series that will use a standardized, evidence-based opioid addiction prevention curriculum to train and inform New Jersey mental health professionals on best practices in treatments available for patients suffering from opioid use disorder. The module will also train and inform on integrated behavioral health services and support to be provided during recovery.
All participants who register for and complete this course will receive access to the New Jersey Opioid Medical Education Program Naloxone Distribution and Training Programs Guide. This comprehensive county-by-county guide, available in interactive and print formats for health care professional reference and patient education, includes pharmacies who dispense NARCAN® (naloxone hydrochloride) Nasal Spray and the recent FDA-approved generic naloxone hydrochloride nasal spray (utilizing standing orders, and via prescription). It also includes virtual trainings in the era of COVID–19 on how and when to use naloxone nasal spray.
TARGET AUDIENCE: Psychologists, Marriage and Family Therapists, Social Workers, Professional Counselors
OBJECTIVES: At the conclusion of this activity, participants will be able to:
- Understand the origins of the opioid epidemic using relevant data.
- Recognize the function of the New Jersey Prescription Monitoring Program (NJ PMP), and mental health professional obligations when providing counseling for patients suffering from opioid use disorder (OUD).
- Understand limitations on psychosocial support including confidentiality, competency, and informed consent for patients on opioid prescriptions for acute pain and chronic pain.
- Identify mental health professional obligations in counseling chronic pain patients in residential treatment facilities and outpatient treatment facilities.
- Practice early intervention and treatment to patients with OUD and those at risk of developing these disorders.
- Understand the effectiveness of medication-assisted treatment (MAT) in treating OUD and special populations.
- Practice or recommend patient communication strategies and non-pharmacological psychosocial interventions including cognitive behavioral therapy (CBT), and relapse prevention (RP).
- Understand trauma-informed care including trauma awareness; safety and trustworthiness; choice, collaboration, and connection; and strengths-based and skill building.
- Recognize reasons to refer patients to addiction treatment, including office-based addiction therapy (OBAT), intensive outpatient services (IOP), and residential services.
- Discuss systemic issues of stigma surrounding patients with OUD and those receiving MAT, and solutions on how stigma can be overcome.
This enduring recorded course satisfies the statutory mandate that mental health professionals obtain one credit of continuing education on prescription opioid-related topics as a condition of licensure renewal.
Upon successful completion of the enduring recorded course, participants will receive a certificate of completion, and should retain it in accordance with their relevant licensing board’s regulations.
To receive full credit, you must be present for the entire enduring recorded course activity.
To receive a certificate of completion, complete the Pre-Assessment, Post-Assessment, and Knowledge Assessment.
Hearing Impaired Registrants: This enduring recorded course will contain closed captioning.
For questions pertaining to the New Jersey Licensing Boards, and questions and/or feedback pertaining to module content, please contact Patricia Fortunato, RowanSOM NMI Content Manager/Program Manager at email@example.com
For technical support with registration and access to the module, please contact the Rowan Online Marketplace Center at (856) 256-5164, or submit an email ticket here.